Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
39,598,228
-
Total 13F shares
-
25,605,992
-
Share change
-
-3,119,810
-
Total reported value
-
$82,661,264
-
Price per share
-
$3.23
-
Number of holders
-
47
-
Value change
-
-$10,626,216
-
Number of buys
-
16
-
Number of sells
-
22
Institutional Holders of Rapid Micro Biosystems, Inc. - Common Stock, par value $0.01 (RPID) as of Q3 2022
As of 30 Sep 2022,
Rapid Micro Biosystems, Inc. - Common Stock, par value $0.01 (RPID) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,605,992 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, KENNEDY LEWIS MANAGEMENT LP, T. Rowe Price Investment Management, Inc., JPMORGAN CHASE & CO, BlackRock Inc., ABG-WTT Global Life Science Capital Partners GP Ltd, PRICE T ROWE ASSOCIATES INC /MD/, GLENVIEW CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
47
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.